Zevra Therapeutics (ZVRA) Institutional Ownership → The ONE AI Stock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad) Free ZVRA Stock Alerts $4.82 -0.21 (-4.17%) (As of 05/10/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Zevra Therapeutics (NASDAQ:ZVRA)CurrentInstitutional OwnershipPercentage35.03%Number ofInstitutional Buyers(last 12 months)24TotalInstitutional Inflows(last 12 months)$11.50MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$183.17K Get ZVRA Insider Trade Alerts Want to know when executives and insiders are buying or selling Zevra Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ZVRA Institutional Buying and Selling by Quarter Ad Weiss RatingsThe ONE AI Stock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …Click here to see the presentation now. Zevra Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/10/2024Vanguard Group Inc.1,704,006$9.88M0.0%+3.6%3.924% 5/7/2024 Retirement Planning Co of New England Inc.430,193$2.50M1.4%+11.0%0.991% 5/7/2024 Mystic Asset Management Inc.266,297$1.55M0.6%+15.4%0.613% 5/7/2024 SG Americas Securities LLC12,680$74K0.0%-39.6%0.029% 5/1/2024 Janney Montgomery Scott LLC660,169$3.83M0.0%-3.4%1.520% 4/25/2024 IFG Advisors LLC18,700$108K0.0%+45.0%0.043% Get the Latest News and Ratings for ZVRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Zevra Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/26/2024Virtu Financial LLC26,966$177K0.0%N/A0.074% 2/13/2024Tower Research Capital LLC TRC9,673$63K0.0%+134.3%0.027% 2/13/2024Armistice Capital LLC268,000$1.76M0.0%N/A0.740% 2/12/2024Focus Financial Network Inc. ADV21,500$141K0.0%N/A0.059% 2/8/2024 Janney Montgomery Scott LLC683,431$4.48M0.0%+1.3%1.887% 2/7/2024Jump Financial LLC33,200$217K0.0%N/A0.092% 2/2/2024 Kovack Advisors Inc.141,401$926K0.1%+13.9%0.390% 1/30/2024Strs Ohio19,400$127K0.0%+151.9%0.054% 1/24/2024 International Assets Investment Management LLC6,550$43K0.0%+555.0%0.018% 1/12/2024 SG Americas Securities LLC20,999$138K0.0%+41.7%0.058% 12/6/2023VisionPoint Advisory Group LLC6,860$33K0.0%N/A0.019% 11/15/2023Laurion Capital Management LP31,200$150K0.0%N/A0.086% 11/13/2023 Retirement Planning Co of New England Inc.347,402$1.67M0.9%N/A0.959% 11/13/2023 Mystic Asset Management Inc.203,283$980K0.6%N/A0.561% 11/8/2023 Janney Montgomery Scott LLC674,369$3.25M0.0%N/A1.988% 11/7/2023 Kingsview Wealth Management LLC12,120$58K0.0%N/A0.036% 10/31/2023 IFG Advisors LLC12,900$62K0.0%N/A0.038% 10/26/2023 Mirae Asset Global Investments Co. Ltd.19,072$92K0.0%N/A0.056% 10/26/2023Strs Ohio7,700$37K0.0%N/A0.023% 10/24/2023 Bank of New York Mellon Corp202,773$977K0.0%N/A0.598% 10/24/2023 Stratos Wealth Partners LTD.70,200$338K0.0%N/A0.207% 10/24/2023 Raymond James Financial Services Advisors Inc.26,228$126K0.0%N/A0.077% 10/23/2023Commonwealth Equity Services LLC10,858$52K0.0%N/A0.032% 10/18/2023 Measured Wealth Private Client Group LLC10,000$48K0.0%N/A0.029% 10/16/2023 City State Bank14,224$69K0.0%N/A0.042% 10/13/2023 SG Americas Securities LLC14,824$71K0.0%N/A0.044% (Data available from 1/1/2016 forward) ZVRA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ZVRA shares? During the previous two years, 24 institutional investors and hedge funds held shares of Zevra Therapeutics. The most heavily invested institutionals were Vanguard Group Inc. ($9.88M), Janney Montgomery Scott LLC ($3.83M), Retirement Planning Co of New England Inc. ($2.50M), Armistice Capital LLC ($1.76M), Mystic Asset Management Inc. ($1.55M), Bank of New York Mellon Corp ($977K), and Kovack Advisors Inc. ($926K).Learn more on ZVRA's institutional investors. What percentage of Zevra Therapeutics stock is owned by institutional investors? 35.03% of Zevra Therapeutics stock is owned by institutional investors. Learn more on ZVRA's institutional investor holdings. Which institutional investors have been buying Zevra Therapeutics stock? Of the 24 institutional investors that purchased Zevra Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Janney Montgomery Scott LLC ($683.43K), Retirement Planning Co of New England Inc. ($390.17K), Armistice Capital LLC ($268K), Mystic Asset Management Inc. ($238.80K), Bank of New York Mellon Corp ($202.77K), Stratos Wealth Partners LTD. ($70.20K), and Vanguard Group Inc. ($58.87K). How much institutional buying is happening at Zevra Therapeutics? Institutional investors have bought a total of 2,211,949 shares in the last 24 months. This purchase volume represents approximately $11.50M in transactions. Which Zevra Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Zevra Therapeutics stock in the last 24 months: Janney Montgomery Scott LLC ($23.26K), and SG Americas Securities LLC ($8.32K). How much institutional selling is happening at Zevra Therapeutics? Institutional investors have sold a total of 31,581 shares in the last 24 months. This volume of shares sold represents approximately $183.17K in transactions. Related Companies: G1 Therapeutics Major Shareholders Puma Biotechnology Major Shareholders uniQure Major Shareholders Merrimack Pharmaceuticals Major Shareholders Emergent BioSolutions Major Shareholders AC Immune Major Shareholders Renovaro Major Shareholders Atossa Therapeutics Major Shareholders Ovid Therapeutics Major Shareholders Generation Bio Major Shareholders This page (NASDAQ:ZVRA) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsBuy this small stock before coming AI Tidal WaveChaikin AnalyticsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressObama’s Forever Term [exposed]Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zevra Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.